[Hypoxemia by pulmonary arteriovenous fistulae in childhood: case report.]

Insights

Cyanosis in a child was treated with pulmonary lobectomy for pulmonary arteriovenous fistulae (PAVF). Postoperative complications arose from a new PAVF, successfully treated with embolization, highlighting the need for ongoing monitoring.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Pulmonology

Context:

  • Cyanosis of unknown origin in children warrants investigation for pulmonary arteriovenous fistulae (PAVF).
  • PAVF can lead to significant hypoxemia and requires timely diagnosis and management.
  • This case highlights a complex pediatric presentation of PAVF.

Purpose:

  • To report a case of cyanosis in a child successfully managed with pulmonary lobectomy for PAVF.
  • To discuss the diagnostic and therapeutic challenges associated with PAVF in pediatric patients.
  • To emphasize the potential for recurrent or new PAVF formation and the importance of long-term follow-up.

Summary:

  • A 3-year-old boy with cyanosis was diagnosed with PAVF via MRI and underwent upper left lobectomy.
  • The patient experienced initial improvement, followed by a decrease in SpO2 due to a new PAVF, which was successfully treated with embolization.
  • The case underscores the potential for Rendu-Osler-Weber Syndrome in patients with PAVF.

Impact:

  • This case demonstrates the efficacy of surgical resection and embolization in managing pediatric PAVF.
  • It highlights the importance of considering underlying genetic syndromes like Rendu-Osler-Weber Syndrome.
  • Long-term surveillance is crucial for patients with PAVF due to the risk of recurrence or new lesion development.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...